ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $92,000 | +736.4% | 2,731 | +296.4% | 0.01% | +500.0% |
| Q1 2020 | $11,000 | 0.0% | 689 | +50.4% | 0.00% | 0.0% |
| Q4 2019 | $11,000 | +22.2% | 458 | +2.7% | 0.00% | 0.0% |
| Q3 2019 | $9,000 | -86.2% | 446 | -78.0% | 0.00% | -80.0% |
| Q2 2019 | $65,000 | +828.6% | 2,026 | +796.5% | 0.01% | +400.0% |
| Q1 2019 | $7,000 | +40.0% | 226 | +18.3% | 0.00% | – |
| Q4 2018 | $5,000 | – | 191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |